← Back to Search

Physiotherapy for Urinary Incontinence in Gynecologic Cancer Survivors

N/A
Recruiting
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Scheduled oncological treatments completed
Stress or mixed urinary incontinence with a frequency of at least three urinary leakage per
Must not have
Pelvic floor rehabilitation in the last year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 2-week post-treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a certain type of physical therapy can help treat urinary incontinence in cancer survivors.

Who is the study for?
This trial is for women who have survived gynecological cancers like endometrial or cervical cancer and are now experiencing urinary incontinence at least three times a week. They should be done with their scheduled cancer treatments but haven't had pelvic floor rehab in the past year, and don't have other conditions that could affect the study.
What is being tested?
The study is testing physiotherapy as a treatment for urinary incontinence against standard care given to survivors of gynecological cancers. It's a pilot study meant to set up for a larger future trial by checking how feasible this approach is.
What are the potential side effects?
Since this trial involves physiotherapy, side effects might include temporary soreness or muscle fatigue from exercises. Unlike drug trials, there's less risk of systemic side effects since it's non-invasive.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have finished all my planned cancer treatments.
Select...
I experience urinary leakage at least three times a week.
Select...
I have had cancer in my reproductive organs.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have undergone pelvic floor rehabilitation in the past year.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 2-week post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 2-week post-treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence rates
Retention rate
Secondary study objectives
Change from baseline in number of urinary leaks
Change from baseline in pelvic floor muscle function
Change from baseline in pelvic floor muscle morphometry
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PhysiotherapyExperimental Treatment1 Intervention
12-weekly physiotherapy treatment sessions.
Group II: Standard usual careActive Control1 Intervention
Participants will be asked to continue the usual care established during the regular follow-up with their medical doctor for 12 weeks.

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)OTHER
377 Previous Clinical Trials
131,476 Total Patients Enrolled
Université de SherbrookeLead Sponsor
304 Previous Clinical Trials
76,685 Total Patients Enrolled
3 Trials studying Urinary Incontinence
198 Patients Enrolled for Urinary Incontinence
Centre de recherche du Centre hospitalier universitaire de SherbrookeOTHER
61 Previous Clinical Trials
33,470 Total Patients Enrolled
2 Trials studying Urinary Incontinence
78 Patients Enrolled for Urinary Incontinence

Media Library

Physiotherapy Clinical Trial Eligibility Overview. Trial Name: NCT03957434 — N/A
Urinary Incontinence Research Study Groups: Physiotherapy, Standard usual care
Urinary Incontinence Clinical Trial 2023: Physiotherapy Highlights & Side Effects. Trial Name: NCT03957434 — N/A
Physiotherapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03957434 — N/A
~5 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top